Stock price graph

Stock Quote


Price: 5.24
Change: 0.00
Day High: N/A
Day Low: N/A
Volume: N/A

4:00 PM ET on Apr 24, 2017

Delayed at least 20 minutes.
Provided by eSignal.

Investors & Media


We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Cyclacel Pharmaceuticals, Inc.'s financial performance into perspective.

Recent Releases

Apr 4, 2017

Cyclacel Presents Identification of Sensitive Target Indications and Synergistic Drug Combinations for Novel PLK1 Inhibitor CYC140

Apr 2, 2017

Cyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Elicits Marked Antineoplastic Effects in Lung Cancer by Engaging Anti-Metastatic Pathways

View All >

Events & Presentations

Mar 28, 2017 at 4:30 PM ET

Fourth Quarter 2016 Financial Results

Feb 23, 2017 at 9:00 AM ET

Phase 3 SEAMLESS Study in AML and Pipeline Update

View All >

Annual Reports


Annual Report

View All >

Investors & Media